Dodge & Cox Eli Lilly & CO Transaction History

Dodge & Cox

$159 Billion
Q2 2024

A detailed history of Dodge & Cox transactions in Eli Lilly & CO stock. As of the latest transaction made, Dodge & Cox holds 45,978 shares of LLY stock, worth $41.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

45,978

Previous 46,925 2.02%

Holding current value

$41.8 Million

Previous $36.5 Million 14.03%

% of portfolio

0.03%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $686,451 - $860,860	-947 Reduced 2.02%	45,978 $41.6 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $4.21 Million - $5.63 Million	-7,104 Reduced 13.15%	46,925 $36.5 Million
Q4 2023 Feb 15, 2024	SELL	$525.19 - $619.13 $504,707 - $594,983	-961 Reduced 1.75%	54,029 $31.5 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $2.02 Million - $2.79 Million	-4,655 Reduced 7.8%	54,990 $29.5 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $672,368 - $899,034	-1,917 Reduced 3.11%	59,645 $28 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $660,088 - $775,242	-2,125 Reduced 3.34%	61,562 $21.1 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $1.93 Million - $2.25 Million	-6,007 Reduced 8.62%	63,687 $23.3 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $440,865 - $502,412	-1,487 Reduced 2.09%	69,694 $22.5 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $427,014 - $501,377	-1,532 Reduced 2.11%	71,181 $23.1 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $1.97 Million - $2.45 Million	-8,395 Reduced 10.35%	72,713 $20.8 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $809,460 - $1 Million	-3,600 Reduced 4.25%	81,108 $22.4 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $243,095 - $299,162	-1,097 Reduced 1.28%	84,708 $19.6 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $1.18 Million - $1.53 Million	-6,561 Reduced 7.1%	85,805 $19.7 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $2.32 Million - $3.01 Million	-14,147 Reduced 13.28%	92,366 $17.3 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $2.46 Million - $3.26 Million	-18,880 Reduced 15.06%	106,513 $18 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $6.61 Million - $7.65 Million	-45,229 Reduced 26.51%	125,393 $18.6 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $16.5 Million - $19.8 Million	-120,885 Reduced 41.47%	170,622 $28 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $928 Million - $1.15 Billion	-7,796,551 Reduced 96.4%	291,507 $40.4 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $78.2 Million - $96.8 Million	-730,995 Reduced 8.29%	8,088,058 $1.06 Billion
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $4.5 Million - $4.89 Million	-42,104 Reduced 0.48%	8,819,053 $986 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $645 Million - $752 Million	-5,818,238 Reduced 39.64%	8,861,157 $982 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $91.4 Million - $108 Million	-821,500 Reduced 5.3%	14,679,395 $1.9 Billion
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $762 Million - $853 Million	-7,192,076 Reduced 31.69%	15,500,895 $1.79 Billion
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $372 Million - $464 Million	-4,327,500 Reduced 16.02%	22,692,971 $2.44 Billion
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $392 Million - $450 Million	5,178,354 Added 23.71%	27,020,471 $2.31 Billion
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $123 Million - $145 Million	1,660,830 Added 8.23%	21,842,117 $1.69 Billion
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $13.2 Million - $14.2 Million	161,210 Added 0.81%	20,181,287 $1.7 Billion
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $1.54 Billion - $1.71 Billion	20,020,077	20,020,077 $1.71 Billion

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account